Global Western Blotting Market 2016-2020
About the Western Blotting Market
Western blotting, also known as protein blotting or immunoblotting, is a technique under molecular biology that is used to detect and analyze proteins. The technique identifies specific proteins from a complex mixture of proteins present in a sample of tissues cells. Western blotting has high accuracy and reproducibility, due to which it is used as a confirmatory test for the diagnosis of HIV.
Technavio’s analysts forecast the global western blotting market to grow at a CAGR of 5.84% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global western blotting market for 2016-2020. To calculate the market size, we have considered the revenue generated from the sales of the following as mostly applied for HIV related activities:
Technavio Announces the Publication of its Research Report – Global Western Blotting Market 2016-2020
Technavio recognizes the following companies as the key players in the global western blotting market: Bio-Rad Laboratories, GE Healthcare, Merck Millipore, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Abcam, Advansta, AMRESCO, Azure Biosystems, Cell Signaling Technology, Cygnus Technologies, KOMA BIOTECH, KPL, Kirkegaard & Perry Laboratories, LI-COR, Lumigen, PerkinElmer, Protein Simple, Roche Applied Science (Roche Diagnostics), and Rockland Immunochemicals.
Commenting on the report, an analyst from Technavio’s team said: “A trend which is boosting market growth immensely is technological advances. Over the years, western blotting has undergone significant changes to make the test more effective, primarily to screen HIV and Lyme diseases. Many companies worldwide have come up with proprietary technologies to ensure high accuracy in the products offered. For instance, GenScript, a biology contract research company, launched western blot kits based on its proprietary western detection technology ONE-HOUR Western, which offers rapid results and is therefore popular in the market. The number of applications of western blotting have multiplied in areas such as agriculture, food and beverage, disease diagnosis, and biomedical and biochemical research, and researchers are therefore looking for western blot tests that can produce results more quickly without sacrificing the sensitivity and quality of the sample under test.”
According to the report, a key growth driver is the prevalence of HIV. HIV infection results in AIDS over a period of time, if the individual does not receive the right treatment. HIV is one of the major causes of death worldwide. In 2014, 36.9 million people were living with HIV/AIDS, of which 2 million were newly infected with the HIV virus. The rapid increase in the number of cases can be attributed to the increase in cases of unprotected sex rising from lack of awareness regarding the transmission of the infection and symptoms of the disease, especially in African countries, which can be attributed to a poor education system leading to a lower literacy rate, and sharing of needles for the consumption of narcotics. There is no cure for AIDS, though antiretroviral drugs can control the spread of the HIV virus to enable people to lead a painless and healthy life, and reduce the risk of transmitting the virus to others.
Further, the report states that one challenge that could restrict market growth is the high cost of primary antibodies.
Bio-Rad Laboratories, GE Healthcare, Merck Millipore, Thermo Fisher Scientific, Abcam, Advansta, AMRESCO, Azure Biosystems, Cell Signaling Technology, Cygnus Technologies, KOMA BIOTECH, KPL, Kirkegaard & Perry Laboratories, LI-COR, Lumigen, PerkinElmer, Protein Simple, Roche Applied Science (Roche Diagnostics), Rockland Immunochemicals.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook